This site uses cookies for analytics and advertising. None of them are stored until you agree. Details
Novo Nordisk A/S
AI synthesizes chart patterns, technical composite scores, earnings surprises, and valuation multiples to build target price scenarios.
This forecast is a statistical estimate based on historical data and does not guarantee future results. Not investment advice.
| Indicator | Value | Signal |
|---|---|---|
| SMA (5) | 45.61 | Sell |
| SMA (20) | 46.12 | Sell |
| SMA (50) | 47.68 | Sell |
| SMA (200) | 46.29 | Sell |
| EMA (12) | 45.76 | Sell |
| EMA (26) | 46.33 | Sell |
| EMA (50) | 46.53 | Sell |
| WMA (20) | 45.97 | Sell |
| DEMA (20) | 45.4 | Sell |
| TEMA (20) | 45.06 | Sell |
| MACD (12, 26, 9) | macd: -0.57 / signal: -0.41 / histogram: -0.16 | Sell |
| ADX / DMI (14) | adx: 11.29 / pdi: 23.17 / mdi: 29.6 | Neutral |
| Ichimoku Cloud (9, 26, 52) | tenkan: 46.11 / kijun: 46.44 / spanA: 47.9 / spanB: 46.56 | Sell |
| Parabolic SAR (0.02, 0.2) | 48.43 | Sell |
| Aroon (25) | up: 56 / down: 100 | Sell |
| Supertrend (10, 3) | supertrend: 48.26 / direction: -1 | Sell |
| Linear Regression Slope (20) | -0.11 | Sell |
| 52-Week High Breakout | high52w: 64.16 / low52w: 35.12 / pctFromHigh: -31.07 | Neutral |
| Cup with Handle (52w) | pivotPrice: 52.12 / handleLow: 44.22 / depthPct: 45.26 | Neutral |
Essential valuation, profitability, and balance sheet metrics viewed on TradingView and financial terminals
Historical quarterly earnings (EPS & surprise) and forward consensus estimates
| Period | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|
| 2025-09 | $4.50 | $4.24 | +6.05% |
| 2025-12 | $6.04 | $5.90 | +2.34% |
| 2026-03 | $6.63 | $6.96 | -4.75% |
| 2026-06 | $6.18 | $4.98 | +24.01% |
| Period | Avg EPS Estimate | EPS Growth Est. | Avg Revenue Estimate | Revenue Growth Est. |
|---|---|---|---|---|
| Current Quarter (0Q) | $5.11 | +13.5% | USD 72.8B | -2.8% |
| Next Quarter (+1Q) | $4.37 | -27.6% | USD 73.9B | -6.7% |
| Current Year (0Y) | $23.03 | 0.0% | USD 299.4B | -3.1% |
| Next Year (+1Y) | $21.98 | -4.6% | USD 303.9B | +1.5% |
Nearest Expiration: Sep 11, 2026
Based on the nearest-expiry options chain.
Symbol-level short-interest metrics and official market-wide margin statistics
The sources below cover the whole market, not this symbol specifically.
FINRA Margin StatisticsAggregate U.S. margin debt, free credit balances in margin accounts, and free credit balances in cash accounts, published monthly by FINRA across all member firms.Cadence: MonthlyJPX Margin Trading Balances (信用取引残高)Weekly margin trading (buy/sell) balances for listed Japanese equities, published by Japan Exchange Group.Cadence: WeeklyJPX Short Selling Statistics (空売り集計)Daily aggregate short-selling value/ratio statistics for the Japanese equity market, published by Japan Exchange Group.Cadence: DailyAnalyst recommendation distribution and price targets
| Date | Firm | Action | Grade |
|---|---|---|---|
| Mar 2, 2026 | Goldman Sachs | down | Buy → Neutral |
| Feb 24, 2026 | JP Morgan | down | Overweight → Neutral |
| Jan 9, 2026 | CICC | init | Outperform |
| Dec 8, 2025 | Argus Research | down | Buy → Hold |
| Nov 28, 2025 | Goldman Sachs | main | Buy → Buy |
| Nov 25, 2025 | BMO Capital | main | Market Perform → Market Perform |
| Nov 24, 2025 | HSBC | down | Buy → Hold |
| Oct 14, 2025 | BMO Capital | main | Market Perform → Market Perform |
| Oct 2, 2025 | HSBC | up | Hold → Buy |
| Sep 29, 2025 | Morgan Stanley | down | Equal-Weight → Underweight |